Research Article: Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics
Introduction:
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver malignancy that was first identified in . FLHCC is recognized as a separate entity rather than a variant of hepatocellular carcinoma, although it is defined as a subtype of hepatocellular carcinoma according to the fifth edition of the World Health Organization (WHO) Classification of Tumours. This type of tumour often presents in the absence of cirrhosis or chronic hepatopathy and is mostly diagnosed in pediatric and young adult population. , The…
Read more